Clinical trial
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs…
NCT00373542 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00373542 |
|---|---|
| Title | 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome |
| Official title | A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep |
| Acronym | (CR-RLS) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome (RLS), Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | ropinirole CR-RLS |
| Enrollment | 39 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 8, 2006 |
| Last update posted | Oct 28, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: